Analyst Activity – HC Wainwright Reiterates Buy on Bioline RX (NASDAQ:BLRX)

Analyst Ratings For Bioline RX (NASDAQ:BLRX)

Story continues below

Today, HC Wainwright reiterated its Buy rating on Bioline RX (NASDAQ:BLRX) with a price target of $4.00.

Some recent analyst ratings include

  • 3/6/2018-HC Wainwright Reiterated Rating of Buy.
  • 12/21/2017-Oppenheimer initiated coverage with a Buy rating.
  • 2/13/2017-Rodman & Renshaw initiated coverage with a Buy rating.

    Recent Trading Activity for Bioline RX (NASDAQ:BLRX)
    Shares of Bioline RX closed the previous trading session at with 1.0099999904632568 shares trading hands.

    An ad to help with our costs